Genetics of Prostate Cancer (PDQ®)–Health Professional Version

SECTIONS

Changes to This Summary (02/16/2018)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Introduction

Updated National Comprehensive Cancer Network (NCCN) as reference 36.

Added text to include metastatic prostate cancer as part of the criteria that may warrant referral for genetic consultation.

Genes With Potential Clinical Relevance in Prostate Cancer Risk

Updated NCCN as reference 33.

Interventions in Familial Prostate Cancer

Updated NCCN as reference 12.

This summary is written and maintained by the PDQ Cancer Genetics Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.

< Previous section
Psychosocial Issues in Familial Prostate Cancer

Next section >
About This PDQ Summary